OMA1 and YME1L as a Diagnostic Panel in Hepatocellular Carcinoma

Researchers evaluated the possible role of OMA1/YME1L in HCC staging and discussed their potential role in cellular apoptosis and proliferation. They used four groups of male albino rats: a normal control and three diethyl nitrosamine-treated groups for 8, 16, and 24 weeks.